(Q34778477)

4 August 2017

Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency (English)

1 reference

4 August 2017

2

Mark D Eisner

1 reference

4 August 2017

5

Paul D Blanc

1 reference

4 August 2017

Theodore A Omachi

1

1 reference

4 August 2017

Alexis Rames

series ordinal

3

1 reference

4 August 2017

Lada Markovtsova

series ordinal

4

1 reference

4 August 2017

23 March 2011

1 reference

4 August 2017

1 reference

4 August 2017

12

1 reference

4 August 2017

35

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-12-35

4 August 2017

0 references

cites work

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

COPD: new lessons from alpha1-antitrypsin deficiency?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Chronic obstructive pulmonary disease: a view from the NHLBI.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Biomarkers in COPD: time for a deep breath

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Predictors of mortality in alpha1-antitrypsin deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

COPD exacerbations: definitions and classifications.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Statistical analysis of correlated data using generalized estimating equations: an orientation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Matrix metalloproteinase-9 in lung remodeling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Do multiple outcome measures require p-value adjustment?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Toward a consensus definition for COPD exacerbations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Expiratory computed tomography for assessment of suspected pulmonary emphysema

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Development of a shuttle walking test of disability in patients with chronic airways obstruction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Retinoid treatment of Emphysema in Patients on the Alpha-1 International Registry. The REPAIR study: study design, methodology and quality control of study assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Volume correction in computed tomography densitometry for follow-up studies on pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

C-reactive protein levels and survival in patients with moderate to very severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

All- trans Retinoic Acid Modulates the Balance of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients With Emphysema *

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-35

Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073899

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

26 October 2018

1 reference

12 December 2020

Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness

1 reference

12 December 2020

Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline

1 reference

12 December 2020

Human 92- and 72-kilodalton type IV collagenases are elastases

1 reference

12 December 2020

Mechanisms for isolated volume response to a bronchodilator in patients with COPD

1 reference

12 December 2020

Panacinar emphysema: CT and pathologic findings

1 reference

12 December 2020

Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD

1 reference

12 December 2020

Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency

1 reference

12 December 2020

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis

1 reference

12 December 2020

A review of alpha-1 antitrypsin deficiency

1 reference

12 December 2020

Comparison of computed density and microscopic morphometry in pulmonary emphysema

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-12-35

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference